MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation announced today that it has filed a patent infringement lawsuit against Aobious, Inc. to protect its intellectual property rights regarding ...
MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation announces the launch of the new Nano-Glo® Dual-Luciferase® Reporter (NanoDLR™) Assay, a two-reporter system that incorporates NanoLuc® luciferase ...
The luciferase assays market is divided geographically into seven regions: Asia-Pacific (excluding Japan), Eastern Europe, Western Europe, North America, Latin America, Middle East & Africa, and ...
Promega Corporation has announced the launch of the new Nano-Glo® Dual-Luciferase® Reporter (NanoDLR™) Assay, a two-reporter system that incorporates NanoLuc® luciferase technology, providing ...
NanoLuc ® Binary Technology, also known as NanoBiT, is an innovative binary complementation solution built on NanoLuc® Luciferase (1). As a 19 kDa enzyme, NanoLuc ® Luciferase generates extremely ...
The Brighterside of News on MSN
Bioluminescent lanterns shed new light on memory formation and synaptic activity
Bioluminescent RNA lanterns have revolutionized the way researchers track RNA activity within living organisms. In a ...
AMES, Iowa -- This year's Nobel Prize for chemistry was given to researchers for their work on illuminating living cells that enables scientists and researchers to study how genes, proteins, and ...
THE FACTS: A protein used in some COVID-19 vaccine research is stirring up bogus conspiracy theories on social media as widespread posts claim the harmless enzyme luciferase has satanic associations. ...
Furimazine substrates are protected by multiple active patents held by Promega. MADISON, Wis., March 05, 2025--(BUSINESS WIRE)--Promega Corporation announced today that it has filed a patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback